Adeniyi Oyebade
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Graduate Student
Graduate Student Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Adeniyi Oyebade's research focuses on the development and application of nanomedicines for therapeutic purposes. His work includes investigating doxorubicin-based ionic nanomedicines for combined chemo-phototherapy of cancer, exploring the role of endocytosis pathways in drug delivery, and studying the enhanced killing of bacteria using antibiotics coupled with photothermal therapy. Oyebade has also examined the potential of targeted drug delivery systems, such as using epidermal growth factor receptors for rapamycin delivery in pancreatic cancer cells.
His publications also extend to materials science, including research on carbon-based anode materials for metal-ion batteries and the physicochemical properties of oils from underutilized citrus seeds. Oyebade collaborates with several researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Nawab Ali, and Mavis Forson, with whom he shares multiple publications.
Metrics
- h-index: 4
- Publications: 9
- Citations: 52
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
-
Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025)
-
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
-
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
-
Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
-
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
-
Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
Collaboration Network
Top Collaborators
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Showing 5 of 7 shared publications
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Showing 5 of 6 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
Similar Researchers
Based on overlapping research topics